Pharmaceuticals News and Research

RSS

Computer-based tools can help improve relationship between patients, healthcare workers

A vast computer based glossary of healthcare terms culled from so-called e-health tools, medical news sites, telemedicine applications, home care-management systems, internet-based public health records, and even health-oriented and medical blogs could help improve the relationship between patients and healthcare workers, according to research published in the International Journal of Electronic Healthcare.

17 Mar 2011

Scientist suggests breaking tangled mucus barrier can help treat cancer

Measuring the mechanical strength of cancer cell mucus layers provides clues about better ways to treat cancer, and also suggests why some cancer cells are more resistant to drugs than others, according to Kai-tak Wan, associate professor of engineering at Northeastern University, Boston, Mass.

17 Mar 2011

UNAIDS, UNDP, WHO release policy brief advising countries on using TRIPS flexibilities to drive down HIV treatment costs

Amid growing concerns over the long-term sustainability of access to affordable HIV/AIDS drugs, UNAIDS, WHO and the U.N. Development Program on Tuesday released a policy brief advising countries on how they can successfully use rules written into the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights to lower the cost of and increase access to HIV treatment, Intellectual Property Watch reports.

17 Mar 2011

PCMA ad campaign warns Mississippi legislators that SB 2445 can increase health care costs

A new ad campaign warns Mississippi legislators that SB 2445 would increase health care costs by granting the State Board of Pharmacy authority to regulate pharmacy benefit managers.

17 Mar 2011

Pharmaron signs agreement to provide Isis with nucleoside phosphoramidites up to 100 kg

Pharmaron has signed an agreement to provide Isis Pharmaceuticals, Inc. with nucleoside phosphoramidites at quantities up to 100 kg. Nucleoside phosphoramidites are fundamental building blocks in the production of antisense therapeutics.

17 Mar 2011

MorphoSys inks manufacturing agreement with Boehringer Ingelheim

MorphoSys AG and Boehringer Ingelheim announced today the signing of a biopharmaceutical manufacturing agreement for therapeutic antibodies. The agreement covers the process development and manufacturing of additional clinical material for MorphoSys's proprietary MOR208 program and other drug candidates. MOR208, a potent monoclonal anti-CD19 antibody, is in development for the treatment of chronic lymphocytic leukemia and potentially other B-cell malignancies. The program is currently being evaluated in a phase 1 clinical trial in the USA by MorphoSys's partner Xencor Inc.

16 Mar 2011

Cortex enters agreement with Biovail to regain AMPAKINE assets and rights

Cortex Pharmaceuticals, Inc. announced that it has entered into an agreement with Biovail Laboratories International SRL, a wholly-owned subsidiary of Valeant Pharmaceuticals International, Inc., to regain the AMPAKINE® assets and rights related to respiratory depression.

16 Mar 2011

NextGen Sciences introduces multiplex protein assay for oncology biomarker discovery

NextGen Group plc is pleased to announce that its subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement and qualification, has launched its first multiple protein assay, plasmadiscovery41, for oncology biomarker discovery and qualification.

16 Mar 2011

Shanghai ChemPartner signs outsource research service agreement with Shenogen Pharma

ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its wholly-owned contract research subsidiary, Shanghai ChemPartner, has signed an outsource research service agreement with Shenogen Pharma Group to develop therapeutic monoclonal antibodies targeting the ER-alpha 36 receptor for cancer treatment.

16 Mar 2011

China Nepstar Chain Drugstore fourth quarter revenues increase 1.0% to US$95 million

China Nepstar Chain Drugstore Ltd., the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2010.

16 Mar 2011

EU parliament approves resolution calling for countries to revise pandemic response

On the heels of the release of a draft report by an independent panel of experts examining the WHO's response to H1N1, BMJ News reports on a recently approved resolution and accompanying report released by the European Union parliament that calls on EU countries to revise their flu prevention plans "to make them more effective, coherent, and flexible" and for the WHO to revise its definition of pandemic to take into account not only geographical spread of disease but also severity.

16 Mar 2011

First ever light-activated, non-surgical treatment for HPV and pre-cancerous lesions of the cervix

A new non-surgical, tissue-preserving therapeutic procedure is being developed to more effectively remove HPV infection and treat precursors of cervical cancer.

16 Mar 2011

On The Issues Magazine examines how environmental health affects women's lives

The Spring 2011 edition of On The Issues Magazine – "The Ecology of Women" – examines how environmental health affects women's lives, particularly the toxins and chemicals that enter our bodies from the air, water, food and consumer products. These toxins are implicated as possible causes of conditions like cancer, early puberty, infertility, miscarriages, and birth defects.

16 Mar 2011

NAFC honors Florida's Cleveland Clinic physician with Continence Care Champion Award

The National Association For Continence awarded Gamal Ghoniem, MD, with the Rodney Appell Continence Care Champion Award at the Society for Urodynamics and Female Urology Awards Reception on March 4, held during the 2011 SUFU Winter Meeting in Phoenix, AZ.

16 Mar 2011

Montreal Heart Institute and Cerenis commence CER-001 Phase 2 study in acute coronary syndrome

The Montreal Heart Institute today announced the start of the Phase 2 CHI-SQUARE (Can HDL Infusions Significantly QUicken Atherosclerosis REgression?) study of CER-001 in patients with acute coronary syndrome (ACS), in collaboration with Cerenis Therapeutics, a biopharmaceutical company developing novel high-density lipoprotein (HDL) therapies to treat cardiovascular and metabolic diseases.

16 Mar 2011

Optimer receives U.S. patent for fidaxomicin to treat CDI

Optimer Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office has issued U.S. Patent 7,906,489 which covers methods of Clostridium difficile infection treatment with fidaxomicin.

16 Mar 2011

Plexxikon selects Clinipace to manage 4 clinical trials for RA treatment

Clinipace Worldwide, a global digital clinical research organization, announced today that Plexxikon Inc., a leader in the structure-guided discovery and development of novel small molecule pharmaceuticals to treat human disease, has selected Clinipace to manage all aspects of four clinical trials comprising a Phase 1 healthy volunteer study, a Phase 1b rheumatoid arthritis study, and two phase 2 oncology studies.

16 Mar 2011

Global settlement agreement reached in Tuschl patents litigation

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced the signing of a global settlement agreement among Alnylam, Max Planck Society ("Max Planck"), the Whitehead Institute for Biomedical Research ("Whitehead") and the University of Massachusetts ("UMass") resolving their ongoing litigation regarding the Tuschl patents.

16 Mar 2011

Bruker launches GC CARE gas chromatography columns

At Pittcon 2011, Bruker has significantly expanded its gas chromatography solutions with the release of Bruker GC CARE gas chromatography columns.

16 Mar 2011

Millennium, SGEN expand ADC collaboration

Seattle Genetics, Inc. announced today that Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, has paid an undisclosed fee to exercise an option to designate a second antigen target under the parties' existing antibody-drug conjugate (ADC) collaboration.

16 Mar 2011

Pharmaceuticals News and Research

Computer-based tools can help improve relationship between patients, healthcare workers

Scientist suggests breaking tangled mucus barrier can help treat cancer

UNAIDS, UNDP, WHO release policy brief advising countries on using TRIPS flexibilities to drive down HIV treatment costs

PCMA ad campaign warns Mississippi legislators that SB 2445 can increase health care costs

Pharmaron signs agreement to provide Isis with nucleoside phosphoramidites up to 100 kg

MorphoSys inks manufacturing agreement with Boehringer Ingelheim

Cortex enters agreement with Biovail to regain AMPAKINE assets and rights

NextGen Sciences introduces multiplex protein assay for oncology biomarker discovery

Shanghai ChemPartner signs outsource research service agreement with Shenogen Pharma

China Nepstar Chain Drugstore fourth quarter revenues increase 1.0% to US$95 million

EU parliament approves resolution calling for countries to revise pandemic response

First ever light-activated, non-surgical treatment for HPV and pre-cancerous lesions of the cervix

On The Issues Magazine examines how environmental health affects women's lives

NAFC honors Florida's Cleveland Clinic physician with Continence Care Champion Award

Montreal Heart Institute and Cerenis commence CER-001 Phase 2 study in acute coronary syndrome

Optimer receives U.S. patent for fidaxomicin to treat CDI

Plexxikon selects Clinipace to manage 4 clinical trials for RA treatment

Global settlement agreement reached in Tuschl patents litigation

Bruker launches GC CARE gas chromatography columns

Millennium, SGEN expand ADC collaboration

Oxygen Measurement eBook - Easily Understand Dissolved Oxygen Measurement eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence